PATIENTS WHO ARE ADMITTED TO HOSPITALIZATION IN HCOR AND WHO HAVE THE CONFIRMED DIAGNOSIS OF CORONA VIRUS, WILL BE ASKED TO CONSENT TO PARTICIPATE IN THIS STUDY THAT INTENDS TO STUDY THE EFFECTIVENESS OF THE REMOTE INTERCESSION PRAYER IN COMBATING THIS DISEASE.
PATIENTS WHO AGREE TO PARTICIPATE IN THE STUDY WILL BE SEPARATED INTO 2 GROUPS, THE
INTERVENTION GROUP AND THE CONTROL GROUP.
THE IDENTITY OF THE PATIENTS WILL BE KEPT IN SECRET AND ONLY THEIR INITIALS WILL BE LISTED.
THE INTERVENTION GROUP WILL RECEIVE DAILY PRAYERS AND THE EVOLUTIONARY CLINICAL RESULTS OF
THE TWO GROUPS WILL BE PURCHASED.
Other: PRAYER
THE PRAYER GROUP WILL RECEIVE ABSOLUTELY THE SAME CARE AS THE CONTROL GROUP PLUS PRAYERS
Other Name: INTERCESSORY PRAYER
Inclusion Criteria:
Patients hospitalized in comun hospital rooms and intensive care units with confirmed
COVID-19.
Exclusion Criteria:
- Patients admitted to the HCor emergency room, diagnosed with COVID-19 infection,
however, without indication for hospitalization
- Patients admitted to the HCor emergency room, diagnosed with COVID-19 infection,
however, without indication for hospitalization.
- Patients 18 years of age or older
- Patients with indication of palliative care and definition of terminality at hospital
admission
- Patients who voluntarily choose not to participate in the study at the time of the •
presentation of the Informed Consent Form.
Hospital do Coracao
Sao Paulo, SP, Brazil
NATHAN V SOUBIHE JR, Principal Investigator
Hospital do Coracao